|  
                  
                 
                 
                 
                  Posted on 1-6-2002 
                Gene-Altered 
                  Mosquito Latest Trojan Horse 
                  By Rick Weiss, Washington Post Staff Writer, Thursday, May 23, 
                  2002; Page A03 
                   
                  Scientists in Cleveland for the first time have created genetically 
                  engineered mosquitoes that have a reduced capacity to transmit 
                  malaria. The 
                  feat points to the possibility of disrupting the scourge by 
                  releasing 
                  gene-altered insects in Asia and Africa, where the disease kills 
                  an 
                  estimated 2 million people every year, most of them children 
                  younger than 
                  5. But that prospect has alarmed some scientists and others 
                  who fear that 
                  such a program could trigger ecological disruption and ultimately 
                  increase, 
                  rather than decrease, the global burden of disease.  
                   
                  Experts said the advance has also brought renewed attention 
                  to the fact 
                  that the United States has yet to promulgate regulations limiting 
                  the 
                  environmental release of genetically engineered insects capable 
                  of 
                  transmitting human or animal diseases. The new work, published 
                  in today's 
                  issue of the journal Nature, is the culmination of 15 years 
                  of efforts by 
                  several competing teams trying to gain control over the genetic 
                  machinery 
                  of the mosquito. Although scientists had previously managed 
                  to insert 
                  various genes into the notoriously irritating insects, none 
                  until now had 
                  succeeded in making a mosquito that blocks the development of 
                  the malarial 
                  parasite inside the insect's body. 
                   
                  That parasite, a single-celled creature called Plasmodium, must 
                  pass 
                  through a mosquito's gut and then be reinjected via mosquito 
                  saliva into 
                  humans or other animals to complete its life cycle. Control 
                  of the disease 
                  has been difficult because plasmodium has developed resistance 
                  to 
                  medicines, mosquitoes have become resistant to insecticides, 
                  and efforts to 
                  develop an effective vaccine have so far failed. Taking a novel 
                  tack, 
                  Marcelo Jacobs-Lorena of Case Western Reserve University and 
                  his colleagues 
                  identified a small protein that binds tightly to a mosquito's 
                  gut lining. 
                  The team then engineered mosquitoes with a gene that allows 
                  the insects to 
                  produce that protein after ingestion of a blood meal. 
                   
                  In experiments, most plasmodium cells failed to pass through 
                  the 
                  mosquitoes' gut lining and could not travel to the insects' 
                  salivary 
                  glands. When the team allowed the mosquitoes to feed on malaria-infected 
                  animals and then later bite uninfected ones, disease transmission 
                  was about 
                  80 percent less likely than with normal mosquitoes. Jacobs-Lorena 
                  suggested 
                  that scientists could knock down wild populations of mosquitoes 
                  with 
                  insecticides and then repopulate the area with laboratory-reared 
                  gene-altered ones. But he acknowledged that five to 10 years 
                  of work might 
                  be needed first. 
                   
                  Additional genes that block other aspects of plasmodium's life 
                  cycle in 
                  mosquitoes ought to be added, he said, to reduce transmission 
                  even more. 
                  Moreover, he said, the work so far has been done only with a 
                  variety of 
                  plasmodium that infects rodents, not people. And the team has 
                  yet to make 
                  engineered mosquitoes of the species that spreads human malaria 
                  in Africa, 
                  where most cases occur. The mosquito species used in the experiment 
                  spreads 
                  malaria in India. 
                   
                  In addition to technical challenges, Jacobs-Lorena added, funding 
                  is 
                  sparse. "It's a poor country's disease. If we had a way to prevent 
                  heart 
                  attacks I'm sure there'd be a line of company executives outside 
                  my office 
                  ready to write checks." But others expressed relief that the 
                  work might 
                  progress slowly, saying recent experiences with gene-altered 
                  crops -- many 
                  of which spread their genes through the environment more widely 
                  than had 
                  been anticipated -- teach that extreme caution is warranted. 
                  "We've had 
                  unexpected results in virtually every area of genetically engineered 
                  organisms," said Andrew Kimbrell, executive director of the 
                  International 
                  Center for Technology Assessment, which has filed petitions 
                  with the 
                  federal government seeking to block the release of engineered 
                  insects until 
                  regulations are drawn. 
                   
                  Andrew Spielman, a professor of tropical public health at Harvard 
                  University, echoed those concerns, saying it would be ecologically 
                  unwise 
                  and probably medically useless to release engineered mosquitoes 
                  in malarial 
                  areas. "The lure of this kind of quick fix is so great that 
                  people tend to 
                  be very sloppy in their thinking," Spielman said. 
                 
                 
                  
                  
                   
               |